We are live on ! Find out more
TC

Tavio Capital Portfolio holdings

AUM $75.4M
1-Year Est. Return 27.99%
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$44.9M
Cap. Flow
+$36.5M
Cap. Flow %
14.85%
Top 10 Hldgs %
100%
Holding
13
New
3
Increased
5
Reduced
1
Closed
3

Top Buys

1
MOH icon
Molina Healthcare
MOH
+$28.2M
2
MCK icon
McKesson
MCK
+$21.9M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$13.6M
4
CNC icon
Centene
CNC
+$10.2M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$9.29M

Top Sells

1
WBA
Walgreens Boots Alliance
WBA
+$18.9M
2
AET
Aetna Inc
AET
+$18.3M
3
HUM icon
Humana
HUM
+$17.6M
4
TDOC icon
Teladoc Health
TDOC
+$1.64M

Sector Composition

1 Healthcare 90.3%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
1
Elevance Health
ELV
$80.9B
$50M 20.33%
263,164
+23,284
+10% +$4.43M
BSX icon
2
Boston Scientific
BSX
$65.4B
$49.4M 20.11%
1,694,366
+180,000
+12% +$4.97M
MOH icon
3
Molina Healthcare
MOH
$11.7B
$36.9M 15.03%
537,192
+433,485
+418% +$28.2M
CNC icon
4
Centene
CNC
$32.8B
$28.7M 11.68%
593,462
+235,950
+66% +$10.2M
UHS icon
5
Universal Health Services
UHS
$9.15B
$22.7M 9.24%
204,697
+2,949
+1% +$332K
MCK icon
6
McKesson
MCK
$98.5B
$21.6M 8.77%
+140,372
New +$21.9M
SPY icon
7
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$13.8M 5.62%
+55,000
New +$13.6M
XBI icon
8
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$10M 4.08%
+115,821
New +$9.29M
TVTX icon
9
Travere Therapeutics
TVTX
$5.27B
$7.32M 2.98%
293,923
– –
TDOC icon
10
Teladoc Health
TDOC
$1.7B
$5.3M 2.16%
160,011
-50,000
-24% -$1.64M
HUM icon
11
Humana
HUM
$48B
– –
-73,098
Closed -$17.6M
WBA
12
DELISTED
Walgreens Boots Alliance
WBA
– –
-241,213
Closed -$18.9M
AET
13
DELISTED
Aetna Inc
AET
– –
-120,240
Closed -$18.3M

Similar funds

PC
Premise Capital Naperville, Illinois $77.3M AUM 14.7% 1-Year Est. Return
EGPO
EnTrust Global Partners Offshore New York $73.2M AUM 32.09% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
MCMT
Moon Capital Management (Tennessee) Knoxville, Tennessee $82.4M AUM 3.53% 1-Year Est. Return
NBG
Nancy B. Gardiner $60.4M AUM 13.19% 1-Year Est. Return
FC
Fayerweather Charles $57.2M AUM 11.87% 1-Year Est. Return
SCM
Signia Capital Management Spokane, Washington $55.7M AUM 10.78% 1-Year Est. Return
MVM
McClain Value Management New Canaan, Connecticut $50.9M AUM 16.06% 1-Year Est. Return

Tavio Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Tavio Capital held 13 positions worth $246M, up 22% from $201M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tavio Capital deployed $36.5M of net new capital in Q3 2017, opening 3 new positions and adding to 5 existing holdings. Its largest new stake was McKesson: 140,372 shares worth $21.6M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Teladoc Health, an estimated $1.64M trimmed.

  • Tavio Capital's largest Q3 2017 buy was McKesson: 140,372 shares worth $21.6M.
  • Tavio Capital added most to Molina Healthcare in Q3 2017, an estimated $28.2M increase.
  • Tavio Capital's biggest Q3 2017 reduction was Teladoc Health, cutting an estimated $1.64M.
  • Tavio Capital fully exited Walgreens Boots Alliance in Q3 2017, selling an estimated $18.9M.
  • Tavio Capital's ten largest holdings make up 100% of its $246M portfolio in Q3 2017.
  • Tavio Capital opened 3 new positions and closed 3 in Q3 2017.
  • Tavio Capital's portfolio value rose 22% quarter-over-quarter to $246M.

Based on Tavio Capital's 13F filing for Q3 2017, filed 30 Oct 2017.